To establish the sensitive polymerase chain reaction(PCR) method and detect porcine circovirus type 2 (PCV2) from intestines and feces of commercial swine herds with or without enteric disease, intestinal samples from 68 pigs and 29 fecal samples from commercial swine farms were collected. A primer set, forward primer 5Ј-GAAGAATGGAAGAAGCGG-3Ј and reverse primer 5Ј-CTCACAGCAGTAGACAGGT-3Ј, could detect the virus at a concentration as low as 2 infectious virions per milliliter under controlled conditions using PK-15 cell-adapted PCV2. The genomic nucleotide sequences of open reading frame 1 (ORF1) PCR products from fecal samples were found to have complete homology with other PCV2s deposited in the GenBank database. Transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV) as the other enteric pathogens were also investigated by performing duplex reverse transcription-PCR (RT-PCR). Among 63 pigs with clinical enteric disease, 18 PCV2s (14 from intestines and 4 from feces), 7 TGEVs from intestines, and 18 PEDVs (14 from intestines and 4 from feces) were detected by PCR and the duplex RT-PCR. In 34 pigs (14 from intestines and 20 from feces) without clinical enteric disease, only PCV2 was detected in 19 pigs (3 from intestines and 16 from feces). Both PEDV and PCV2 were found in 6 pigs with clinical enteric disease. Among 15 PCV2 samples that were PCR-positive, 4 were culture-positive at passage level 3 in PK-15 cells. These results reveal that PCV2 is shed through the feces of pigs without clinical enteric disease, which suggests the potentiality of the fecal-oral transmission of PCV2 in feces.
Porcine circovirus (PCV), a small, nonenveloped, circular, single-stranded DNA virus of the Circoviridae family, was originally identified and described as a contaminant of the porcine kidney cell lines. 16, 18 The virus was nonpathogenic in experimentally infected pigs. 3, 19 Recently, PCV has been thought to be associated with a new clinical condition found in pigs shortly after weaning and fattening known as postweaning multisystemic wasting syndrome (PMWS), which was first seen in western Canada in 1991. 5 Postweaning multisystemic wasting syndrome is characterized by progressive weight loss, respiratory signs, jaundice, and diarrhea. The PMWS-associated PCV, namely PCV type 2 (PCV2), is antigenically and genomically different from the nonpathogenic PCV now referred to as PCV1. 4, 5, 8, 15 Severe lesions associated with PMWS have been reproduced experimentally using PCV2; however, the specific pathogenic role and modes of transmission of PCV2 are still unclear. 1 Concerns have heightened because of the uncertainties surrounding the modes of viral transmission and the introduction of the virus into the herd. To develop and implement successful prevention and control programs for PCV2, a thorough understanding of its epidemiology is needed.
PCV2 can be detected in several tissues and organs such as lung, tonsil, lymph node, thymus, spleen, intestine, kidney, liver, serum, salivary gland, and testes after experimental infection. 6, 10, 13 Furthermore, detection of viral nucleic acids of the virus in nasal swabs and semen has suggested potential modes of horizontal and vertical spreading. 9, 10, 13 In addition, detection of PCV2 antigens in the intestinal epithelium demonstrated that feces may play a significant role in the dissemination of PCV2. 17 However, little information is available on patterns of PCV2 excretion into the feces. 1 Thus, to investigate PCV2 in the feces of pigs with or without enteric disease, the authors of this article established a sensitive polymerase chain reaction (PCR) method and detected the virus from intestines and feces of commercial swine herds. The genomic nucleotide sequences of open reading frame 1 (ORF1) PCR products of PCV2 isolates were compared with the published nucleotide sequences from the GenBank database. a Furthermore, other causative agents of enteric disease, transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV), were also tested through a duplex reverse transcription-PCR (RT-PCR). 11 Samples were obtained from suckling pigs and feces submitted to the Virology Laboratory, College of Vet- 2) into 10% suspensions (vol/vol). The feces were also diluted 1:10 (vol/vol) in PBS and vortexed. Both suspensions were clarified through centrifugation for 10 minutes at 4,800 ϫ g. 7 For DNA extraction, 500 l cell lysis buffer containing 27% sucrose, saline sodium citrate (15 mM trisodium citrate and 0.15 M NaCl, pH 7.0), 1 mM ethylene diaminetetraacetic acid (EDTA), 1% sodium dodecyl sulphate, and 200 l/ml proteinase K was mixed with 200 l of the sample solution, which was then thoroughly vortexed and incubated for 8 hours at 37 C. Subsequently, an equal volume of phenol-chloroform-isoamyl alcohol mixture (25:24:1) was added to the preparation, which was thoroughly vortexed and centrifuged for 15 minutes at 12,000 ϫ g. Deoxyribonucleic acid containing the aqueous phase was precipitated with an equal volume of isopropanol, reacted for 2 hours at Ϫ20 C, and centrifuged again. The DNA pellet was washed with 1 ml of 70% ethanol and centrifuged. The supernatant was removed, and the pellet was dried completely and resuspended in 50 l Tris-EDTA buffer. For RNA extraction, the phenol-guanidine isothiocyanate extraction method was used as described previously. 11 The resulting nucleic acids were stored at Ϫ70 C until use.
Primers of PCV2, targeted to the deletion part of PCV1 sequence when compared with reference PCV2, PCV-2A strain 9 , were designed on the basis of a published PCV ORF1 sequence (GenBank accession number U49186) using the primer computer program. b Primers, designated VF2 (forward primer), 5Ј-GAA-GAATGGAAGAAGCGG-3Ј (nucleotide positions 62 to 79), and VR2 (reverse primer), 5Ј-TGGACAGAT-GACGACACTC-3Ј (nucleotide positions 403 to 421), were commercially synthesized. c The size of the amplified product was predicted to be 360 bp. Amplification was carried out using a commercial amplification system. d The reaction mixture (25 l) consisted of 2 l of viral template DNA, 2.5 l of 10ϫ PCR buffer (10 mM Tris-HCl, 50 mM KCl, 0.1% Triton X-100), 2 mM MgCl 2 , 0.2 mM each diethylnitrophenyl thiophosphate, 20 pM each of VF2 and VR2, and 1 unit of Taq DNA polymerase. Samples were amplified using a program that included an incubation for 5 minutes at 94 C, followed by 35 cycles of denaturation for 30 seconds at 95 C, annealing for 30 seconds at 56 C, and extension for 30 seconds at 72 C. At the final completion step, samples were kept for 7 minutes at 72 C and then cooled. Polymerase chain reaction products were analyzed through electrophoresis in 1.5% agarose gel containing 0.5 mg/ml of ethidium bromide.
To determine the sensitivity of PCR, DR673 isolate (10 7.0 TCID 50 /ml-titer based on PCR results) of PCV2 that had been successfully passaged 5 times was used. Serial 10-fold dilutions of the virus were made in minimal essential medium (MEM). To determine the sensitivity of PCR, 10% suspension of a suspected intestinal sample was serially diluted in PBS. Two hundred microliters of the intestinal suspension dilution was added to 200 l of the homogenized intestine containing stool that was PCV-negative. The preparation was then extracted and assayed as described above. To determine the titer of a PCV2 isolate from a suspected intestinal sample, sample dilutions filtered through a 0.2-m syringe filter were inoculated into a 25-cm 2 tissue culture flask containing semiconfluent PK-15 cells free of PCV. The cultures were adsorbed for 2 hours at 37 C in 5% CO 2 atmosphere. The cells were treated with 300 mM D-glucosamine and further incubated for 48 hours. Subsequently, the cells were used to extract and amplify PCV2 DNA. The specificity of the PCR products was demonstrated by sequencing and testing other porcine viruses. PCV2 was detected through the PCR method as described above. Other enteric pathogens, TGEV and PEDV, were also detected by performing a differential duplex RT-PCR assay as described previously. 11 For PCV2 isolation, PK-15 cells free of PCV and porcine parvovirus contamination were maintained in Dulbecco MEM (DMEM) supplemented with 3% fetal bovine serum, e 20 mM N-2-hydroxythylpiperazine-NЈ-2-ethane-sulfonic acid, 300 mM L-glutamine, 0.2% (wt/vol) sodium bicarbonate, and antibiotic-antimycotic mixture (100 IU/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml amphotericin B). e The cells (5 ϫ 10 5 cells/ml) were transferred into 25-cm 2 tissue culture flasks, and the flasks were incubated at 37 C under a humid 5% CO 2 atmosphere for 16 hours. The resulting semiconfluent monolayer was inoculated with 500 l of each supernatant sample, which was filtered previously through a 0.2-m syringe filter. Two flasks were allocated for each sample. After absorption for 2 hours at 37 C, the inoculum was removed. The cell monolayers were then treated with 300 mM Dglucosamine f,4 and further incubated for 48-72 hours. After incubation, 1 flask per sample was frozen and thawed 3 times, and the other was used for DNA extraction. PCV2 growth was detected by PCR.
Sequencing of ORF1 PCR product was performed using PCV2 isolates, DR650 and DR673, from intestinal samples to confirm the specificity of PCV2 primers in both directions. The PCR products were purified using a DNA purification kit. g Sequencing reactions were visualized on an automated sequencer. h The raw data obtained were subsequently edited and aligned to a published sequence using the multiple sequence alignment program. i Polymerase chain reaction amplification using the selected primers revealed a DNA fragment of the expected 360-bp size. Polymerase chain reaction in controlled experiments of PK-15 cell adapted PCV2 (DR673) could detect the virus at a concentration as low as 2 ϫ 10 0 TCID 50 /ml (Fig. 1A) . However, PCR sensitivity of the intestinal samples was lower, detecting the virus at 2 ϫ 10 1 TCID 50 /ml (Fig. 1B) . In an experiment to analyze the specificity of the PCR using a negative control, pseudorabies virus, porcine parvovirus, and DNA obtained from PK-15 cells persistently infected with PCV1, no signals were detected.
Among the 63 pigs with clinical enteric disease, 18 PCV2 (14 intestine and 4 fecal samples), 18 PEDV (14 intestine and 4 fecal samples), and 7 TGEV from intestines were detected. Dual infections of TGEV and PEDV or TGEV and PCV2 were not detected; however, dual infection of PCV2 and PEDV was detected in 6 pigs. In addition, among 34 pigs without clinical enteric disease, PCV2 was detected in only 3 intestine and 16 fecal samples (Table 1) .
Among 15 samples that were PCV2 PCR-positive, 4 were culture-positive at passage level 3. Three PCV2 isolates were continuously proliferated in PK-15 cell cultures more than passage level 10. The isolates were designated DR650, DR673, and E693 strains ( Table 2) . No cytopathic effects (CPEs) were observed in the cells. The viral replication was monitored by immunostaining of cell cultures inoculated with their field materials against PCV-specific polyclonal antibody at the first passage, and the titer of PCV2 was definitively confirmed by PCR specific for PCV2 at each passage. In addition, to check PCV contamination of PCV-free PK-15 cells used for the virus isolation, the authors tested DNA preparations isolated from the continuous PK-15 cell line. All attempts to amplify PCV DNA from the cells failed.
Furthermore, DNA sequence analysis of ORF1 PCR products of PCV2 isolates (DR650 and DR673) showed that the products shared 99% homology with the genome of PCV2 in GenBank (No. AF027217) (Fig. 2) . Continuous passage and adaptation of these isolates to cell cultures may have not resulted in genetic mutation or selection. In addition, the isolates from clinical samples shared 100% nucleotide sequence homology with each other.
In the PCR for PCV2, although PCV2 from intestines could be detected at the lower detection limit of 2 ϫ 10 1 TCID 50 /ml determined through PCR using DNA extracted from 10-fold dilution of PCV2, DR673 strain in cell cultures was detected at 2 ϫ 10 0 TCID 50 / ml; nevertheless, the sensitivity of the PCR was similar to that reported previously. 12 With high PCR primer specificity, the detection limit was 2 ϫ 10 1 TCID 50 /ml for the PCR and 2 ϫ 10 0 TCID 50 /ml for the nest PCR assay in cell cultures. 12 These results suggest that PCR may be applied for the monitoring of virus proliferation or used as a diagnostic tool for PCV2 detection. 9 In this study, the primer designs were on the basis of GenBank search to differentiate PCV2 from PCV1. In addition, nucleotide sequencing of ORF1 PCR products was performed to reveal the extent of homology with the published PCV2 sequences.
Using the established PCR assay, the presence of PCV2 nucleic acid in clinical samples was tested in commercial swine during 1999-2002. The overall detection rate of PCV2 (38.1%) was higher than that reported for PCV2 infection (26.8%) by PCR screening of the organ samples randomly collected from German pigs not affected with PMWS. 14 Eighteen (28.6%) pigs with clinical enteric disease and 19 (55.9%) pigs without clinical enteric disease had PCV2. Furthermore, this study revealed the presence of both PEDV and PCV2 in 6(9.5%) of the enteric disorder cases, which suggests that PCV2 could be horizontally transmitted during the clinical outbreak of enteric diseases such as porcine epidemic diarrhea (PED). Dual infections of TGEV and PCV2 were not detected in the present study, which may be because PED outbreaks has been more frequent than TGE outbreaks in Korea in recent years. Although the numbers of samples were insufficient, detection of PCV2 from pigs with or without clinical enteric disease indicates that PCV2 may be released routinely with feces of pigs with or without clinical enteric disease. Thus, the fecal-oral spreading of PCV2 may be a practical mode of transmission of this virus.
To examine the presence of infectious virus in PCRpositive samples, virus isolation was performed. Two types of PCV, PCV1 and PCV2, have been identified and characterized. PCV1 was found in association with the continuous PK-15 cell line (ATCC CCL33), persistently infected with the virus. 18 Thus, PCV-free PK-15 cells are crucial for PCV isolation. Because a PCVinduced CPE is yet unreported, viral isolations were monitored through immunofluorescent assay (FA), immunoperoxidase staining of infected cell cultures, or PCR. 2, 9 Results of FA and immonuperoxidase staining indicated some degree of antigenic cross-reactivity between PCV2 and PCV1. 4 However, the established PCR assay overcomes this obstacle. In addition, 3 isolates were continuously adapted in PCV-free PK-15 cell cultures by passage level 10, sensitivity test of PCV2 PCR using PCV2, DR673 isolate could be easily performed in this study.
In the swine industry, knowledge on the introduction of the virus and the modes of spreading of the newly emerging porcine disease are critical for the prevention and eradication of PCV2. However, more samples should be collected for performing a practical investigation of PCV2 prevalence. Although PCR for the PCV2 detection in clinical samples is useful because of its speed, specificity, and sensitivity, the transmission of infectious PCV2 in the intestines and feces could not be definitely confirmed. Further work is needed to characterize the isolates in vitro and in vivo.
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